Planet Labs PBC (PL-WT)
Planet Labs PBC (PL-WT)
| Cash Flow | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 |
|---|---|---|---|---|
| Revenue | NaN | 244,352 | NaN | NaN |
| Cost of revenue | NaN | 63,696 | NaN | NaN |
| Research and development | NaN | 73,883 | NaN | NaN |
| Sales and marketing | NaN | 63,852 | NaN | NaN |
| General and administrative | NaN | 53,548 | NaN | NaN |
| Depreciation and amortization | NaN | 45,637 | NaN | NaN |
| Stock-based compensation | NaN | 48,485 | NaN | NaN |
| Restructuring costs | NaN | 10,574 | NaN | NaN |
| Employee transaction bonuses in connection with the sinergise business combination | NaN | 0 | NaN | NaN |
| Certain litigation expenses | NaN | 799 | NaN | NaN |
| Other segment items | NaN | 7,074 | NaN | NaN |
| Net loss | -246,860 | -123,196 | -140,509 | -161,966 |
| Depreciation and amortization | 41,825 | 45,637 | 47,639 | 43,330 |
| Stock-based compensation, net of capitalized cost of 2,605, 2,339 and 2,344, respectively | 54,995 | 48,485 | 57,132 | 75,544 |
| Change in fair value of convertible notes and warrant liabilities | NaN | NaN | -13,709 | -6,554 |
| Change in fair value of warrant liabilities | 161,400 | 15,116 | NaN | NaN |
| Change in fair value of contingent consideration | 465 | 3,437 | -741 | NaN |
| Debt extinguishment loss | NaN | NaN | 0 | 0 |
| Deferred income taxes | NaN | NaN | NaN | -456 |
| Amortization of debt discount and issuance costs | NaN | NaN | 0 | 0 |
| Impairment of capitalized internal-use software | NaN | NaN | 0 | 0 |
| Other | 1,225 | -920 | -4,321 | 52 |
| Accounts receivable | 30,225 | 11,984 | 2,658 | -6,313 |
| Inventories | 609 | NaN | NaN | NaN |
| Prepaid expenses and other assets | 11,138 | -8,366 | -10,498 | 10,080 |
| Accounts payable, accrued and other liabilities | 13,800 | -13,337 | -25,014 | -2,986 |
| Deferred revenue | 151,054 | 15,572 | 22,237 | -14,387 |
| Deferred hosting costs | -1,570 | -1,550 | -1,265 | -2,743 |
| Deferred rent | NaN | NaN | 0 | 0 |
| Net cash provided by (used in) operating activities | 134,362 | -14,374 | -50,711 | -73,933 |
| Purchases of property and equipment | 76,714 | 44,297 | 37,991 | 10,440 |
| Capitalized internal-use software | 4,783 | 5,322 | 4,419 | 2,320 |
| Maturities of available-for-sale securities | 90,009 | 61,396 | 161,317 | 55,172 |
| Sales of available-for-sale securities | 33,229 | 192,522 | 45,580 | NaN |
| Purchases of available-for-sale securities | 428,008 | 140,240 | 189,142 | 280,297 |
| Business acquisition, net of cash acquired | 5,400 | 1,068 | 7,542 | 3,821 |
| Purchases of licensed imagery intangible assets | 1,451 | 4,785 | NaN | NaN |
| Other | 0 | 300 | 1,389 | 557 |
| Net cash provided by (used in) investing activities | -393,118 | 57,906 | -33,586 | -242,263 |
| Proceeds from the exercise of common stock options | 27,708 | 4,375 | 7,388 | 14,701 |
| Payments for withholding taxes related to the net share settlement of equity awards | 72,729 | 11,938 | 8,971 | 6,337 |
| Proceeds from employee stock purchase program | 2,802 | 1,549 | NaN | NaN |
| Proceeds from the early exercise of common stock options | NaN | NaN | 0 | 0 |
| Payments of contingent consideration for business acquisitions | 4,047 | 8,783 | NaN | NaN |
| Proceeds from business combination and pipe investment, net of transaction costs | NaN | NaN | 0 | 0 |
| Payment of indemnification holdback for business acquisition | 5,000 | NaN | NaN | NaN |
| Principal payment of debt | NaN | NaN | 0 | 0 |
| Proceeds from issuance of convertible notes, net of discount | 448,759 | NaN | NaN | NaN |
| Proceeds from issuance of debt and common stock warrants, net of issuance costs | NaN | NaN | NaN | 0 |
| Payment of debt issuance costs | 2,929 | NaN | NaN | NaN |
| Principal payment of convertible notes | NaN | NaN | NaN | 0 |
| Proceeds from the exercise of warrants | 4,845 | NaN | NaN | NaN |
| Proceeds from issuance of convertible notes and preferred stock warrant | NaN | NaN | NaN | 0 |
| Purchase of capped call transactions | 39,560 | NaN | NaN | NaN |
| Other | -2,797 | -738 | -15 | -504 |
| Net cash provided by (used in) financing activities | 357,052 | -15,535 | -1,598 | 7,860 |
| Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents | 7,264 | -201 | 17 | -402 |
| Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalent | 105,560 | 27,796 | -85,878 | -308,738 |
| Cash and cash equivalents, and restricted cash and cash equivalents at the beginning of the period | 129,994 | 102,198 | 188,076 | 496,814 |
| Cash and cash equivalents, and restricted cash and cash equivalents at the end of the period | 235,554 | 129,994 | 102,198 | 188,076 |